SIGN UP FOR UPDATES

IDELVION Safety Profile–low incidence of side effects

5 of 111 people had drug-related side effects in the clinical study.

Only 5 of 111 people had drug-related side effects in the clinical studies
Drug-related side effects in only 5 of 111 people in the clinical studies

IDELVION was evaluated for safety. In the clinical trials, there were:

Zero development of inhibitors in people previous treated in IDELVION clinical trials

development of inhibitors in people previously treated

Zero signs of thrombosis (abnormal blood clots) in IDELVION clinical trials

signs of thrombosis
(abnormal blood clots)

You are now leaving the current website.

Do you want to continue?

No Yes